October 20, 2026
| Steve Scherer
Asia, Europe, North America
Roche’s pact with Hansoh underscores China’s growing importance in supplying experimental medicines, supported by rapid development and greater trust in its science. Hansoh will receive $400 million upfront an... (more story)